Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01306916 · ClinicalTrials.gov registry record

Coexisting Thyroid Disease and Hyperparathyroidism

A clinical trial of Hyperthyroidism, sponsored by Walter Reed Army Medical Center.

Completed
Registry status
30
Enrollment target
1
Study location

NCT01306916: Completed study of Hyperthyroidism, sponsored by Walter Reed Army Medical Center.

NCT01306916 is a study of Hyperthyroidism that has completed, run by Walter Reed Army Medical Center. The registered enrollment target is 30 participants, below the 673-participant average among 4 other Hyperthyroidism trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01306916, a study of Hyperthyroidism, has completed, sponsored by Walter Reed Army Medical Center.

COMPLETED
Registry status
30 participants
Enrollment target
1
Study location

Study Summary

Purpose: Prospective studies of patients with hyperparathyroidism are warranted to determine the prevalence of concurrent thyroid disease applying the current standard of pre-operative radioscintigraphic and sonographic imaging of the neck. Timely diagnosis and treatment of co-existing thyroid disease is advantageous given the well-established increased morbidity associated with a second neck exploration. The purpose of this study is to determine the prevalence and specific type of thyroid disease in patients with hyperparathyroidism, and to determine the frequency with which the presence of thyroid disease alters the treatment plan for patients with hyperparathyroidism. Research Design: This will be a prospective single arm observational study of up to 200 military health care beneficiaries over the age of 18 years with primary and secondary hyperparathyroidism scheduled to undergo parathyroid resection. Methodology: Patients will undergo standard pre-operative imaging of the neck including ultrasonography and 99mTc-sestamibi scintigraphy. An operative plan will be developed based on the information obtained from history, physical examination, laboratory studies, and imaging studies. The number and type of thyroid disease in these patients will be determined based on these non-invasive studies (Objective A). A change in the otherwise standard treatment will include those patients having partial or complete resections of their thyroid glands because: a) the patients would have undergone minimally invasive surgery if not for the results of the imaging studies, and, b) the patients who would have undergone 3 ½ gland parathyroidectomy if not for the results of the imaging studies (Objective B).

Conditions Studied

Study Locations (1)

District of Columbia

  • Walter Reed Army Medical Center - Washington D.C.

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2004-09
Est. Completion 2012-07
Walter Reed Army Medical Center

24 total trials

What the finished NCT01306916 record still lists

NCT01306916 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 673-participant average among 4 other Hyperthyroidism trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Hyperthyroidism appearing as the primary indexed condition, and to 0 interventions.

NCT01306916 reports a single indexed study location in District of Columbia.

Frequently Asked Questions

What is clinical trial NCT01306916 about?

NCT01306916 is a clinical study titled "Coexisting Thyroid Disease and Hyperparathyroidism". Purpose: Prospective studies of patients with hyperparathyroidism are warranted to determine the prevalence of concurrent thyroid disease applying the current standard of pre-operative radioscintigraphic and sonographic imaging of the neck. Timely diagnosis and treatment of co-existing thyroid disea...

What is the current status of trial NCT01306916?

This trial is currently completed. The enrollment target is 30 participants. The study started on 2004-09. Estimated completion is 2012-07.

What conditions does trial NCT01306916 study?

This clinical trial studies the following conditions: Hyperthyroidism.

Who is sponsoring clinical trial NCT01306916?

This trial is sponsored by Walter Reed Army Medical Center, which has 24 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01306916 being conducted?

This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hyperthyroidism

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01306916, the US trial registry maintained by the National Library of Medicine. NCT01306916 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.